{
    "nctId": "NCT05652569",
    "briefTitle": "CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer",
    "officialTitle": "Comprehensive Assessment of Clinical Features and Biomarkers to Identify Patients With Advanced or Metastatic Breast Cancer for Marker Driven Trials in Humans (CATCH)",
    "overallStatus": "RECRUITING",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 5000,
    "primaryOutcomeMeasure": "Setup of the molecular profiling diagnostic platform and feasibility of genomic profiling in metastatic breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female and male breast cancer patients \u2265 18 or if the legal guardian has agreed to the respective informed consent form (ICF)\n* Patients with advanced or metastatic breast cancer (irrespective of clinical parameters such as TNM, subgroups, therapy lines)\n* Patients, who agreed to and were able to sign the informed consent form.\n\nExclusion Criteria:\n\n* Early breast cancer\n* Inability to take a tissue bioptic sample due to reasons such as physical location of the lesion or health of the patient\n* Any physical or mental handicap or severe comorbidities that would hamper the adequate cooperation with the patient.",
    "sex": "ALL",
    "minimumAge": "14 Years",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}